FLT4 and Alzheimer disease: Selective VEGFR3 ligands have shown to improve clearance of immunogenic epitopes from brain (Leppänen et al., 2013; Cho et al., 2017), which suggest a path to an improved removal of aggregated proteins and better immuno-surveillance of AD brain tissue.